All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-CQ2505 | Anti-SLC2A3 (CBXS-0453) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXS-0453 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ5929 | Anti-SLC2A3 (CBXS-0453) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXS-0453 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY0703 | Anti-SLC2A3 (CBFYH-2763) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYH-2763 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3956 | Anti-SLC2A3 (CBFYH-2763) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYH-2763 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY3416 | Anti-SLC2A3 (202017) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 202017 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY3417 | Anti-SLC2A3 (11C103) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse, Rat, Human | 11C103 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY3418 | Anti-SLC2A3 (CBLG1-3106) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBLG1-3106 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY3554 | Anti-SLC2A3 (202017) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 202017 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY3555 | Anti-SLC2A3 (11C103) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse, Rat, Human | 11C103 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY3556 | Anti-SLC2A3 (CBLG1-3106) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBLG1-3106 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-0320ZP1981 | Anti-SLC2A3 (JA50-31) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | JA50-31 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0320ZP1982 | Anti-SLC2A3 (JA50-31) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | JA50-31 | Rabbit | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION